These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11028754)

  • 1. Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors.
    Katori M; Majima M
    Inflamm Res; 2000 Aug; 49(8):367-92. PubMed ID: 11028754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cyclooxygenases in inflammation, cancer, and development.
    Williams CS; Mann M; DuBois RN
    Oncogene; 1999 Dec; 18(55):7908-16. PubMed ID: 10630643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The advent of highly selective inhibitors of cyclooxygenase--a review.
    Cryer B; Dubois A
    Prostaglandins Other Lipid Mediat; 1998 Aug; 56(5-6):341-61. PubMed ID: 9990677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase 2: from inflammation to carcinogenesis.
    Ristimäki A
    Novartis Found Symp; 2004; 256():215-21; discussion 221-6, 259-69. PubMed ID: 15027493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cyclooxygenase-1 and -2 in health and disease.
    Lipsky PE
    Am J Orthop (Belle Mead NJ); 1999 Mar; 28(3 Suppl):8-12. PubMed ID: 10193997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current topics in the regulation of prostanoids-1. Inducible cyclooxygenase COX-2 and selective blockers].
    Ohara M; Sawa T
    Masui; 1998 Nov; 47(11):1325-32. PubMed ID: 9852696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-1 and COX-2 in health and disease.
    Adelizzi RA
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S7-12. PubMed ID: 10643175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "aspirin" of the new millennium: cyclooxygenase-2 inhibitors.
    Buttar NS; Wang KK
    Mayo Clin Proc; 2000 Oct; 75(10):1027-38. PubMed ID: 11040851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2: a therapeutic target.
    Turini ME; DuBois RN
    Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice.
    Reese J; Zhao X; Ma WG; Brown N; Maziasz TJ; Dey SK
    Endocrinology; 2001 Jul; 142(7):3198-206. PubMed ID: 11416042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific COX-2 inhibitors in arthritis, oncology, and beyond: where is the science headed?
    Lipsky PE
    J Rheumatol Suppl; 1999 Apr; 56():25-30. PubMed ID: 10225537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2.
    Morteau O; Morham SG; Sellon R; Dieleman LA; Langenbach R; Smithies O; Sartor RB
    J Clin Invest; 2000 Feb; 105(4):469-78. PubMed ID: 10683376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis.
    Zhang X; Morham SG; Langenbach R; Young DA; Xing L; Boyce BF; Puzas EJ; Rosier RN; O'Keefe RJ; Schwarz EM
    J Bone Miner Res; 2001 Apr; 16(4):660-70. PubMed ID: 11315993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2 in brain and spinal cord implications for therapeutic use.
    Hoffmann C
    Curr Med Chem; 2000 Nov; 7(11):1113-20. PubMed ID: 11032961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice.
    Saukkonen K; Tomasetto C; Narko K; Rio MC; Ristimäki A
    Cancer Res; 2003 Jun; 63(12):3032-6. PubMed ID: 12810622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coxibs: cyclooxygenase-2 inhibitors].
    Turnheim K
    Wien Klin Wochenschr; 2001 Aug; 113(15-16):558-65. PubMed ID: 11571832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of prostaglandin H synthase 2 deficient mice and implications for mechanisms of NSAID action.
    Morham SG; Langenbach R; Mahler J; Smithies O
    Adv Exp Med Biol; 1997; 407():131-8. PubMed ID: 9321943
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent development of selective cyclooxygenase-2 inhibitors].
    Kawai S
    Nihon Rinsho; 2002 Dec; 60(12):2370-7. PubMed ID: 12510364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the mouse cyclooxygenase 1 gene. Characteristics of the mutant and areas of future study.
    Langenbach R; Morham SG; Tiano HF; Loftin CD; Ghanayem BI; Chulada PC; Mahler JF; Davis BJ; Lee CA
    Adv Exp Med Biol; 1997; 407():87-92. PubMed ID: 9321936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The COX-2 inhibitor NS-398 causes T-cell developmental disruptions independent of COX-2 enzyme inhibition.
    Xu H; Izon DJ; Loftin C; Spain LM
    Cell Immunol; 2001 Dec; 214(2):184-93. PubMed ID: 12088417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.